echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > [Zhou Jun] the "epidemic" of small and micro enterprises is the most affected; the clinical diagnosis results confirmed patients, supported by who; the emergence of new pneumonia "antibody", which is expected to significantly reduce the number of critically ill patients

    [Zhou Jun] the "epidemic" of small and micro enterprises is the most affected; the clinical diagnosis results confirmed patients, supported by who; the emergence of new pneumonia "antibody", which is expected to significantly reduce the number of critically ill patients

    • Last Update: 2020-02-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    ● focus of this week: 1 Financial and tax support for enterprises affected by the epidemic: small and micro enterprises are the most obvious; 2 Clinical diagnosis results confirm patients, supported by who; 3 New coronavirus is named sars-cov-2, disease name is covid-19; 4 New pneumonia "antibody" appears, which is expected to significantly reduce the mortality of critical patients; government highlights The novel coronavirus pneumonia diagnosis and treatment plan (trial version fifth) is applicable throughout the country: all regions should be implemented in accordance with this standard In February 11th, the joint defense joint control mechanism of the State Council held a news conference in Beijing to introduce the situation of strengthening the prevention and control of rural epidemic situation Novel coronavirus pneumonia treatment plan (trial version fifth) was developed by the national health and Health Committee (trial version of the first edition), which is applied to the whole country This standard takes into account the clinical manifestations and imaging tables of the disease, according to Mi Feng, deputy director of the national health and health Committee and propaganda department The results of current and etiological tests are in line with the current characteristics of the disease, and should be carried out in accordance with this standard in all parts of the country Financial and tax support for enterprises affected by the epidemic: on February 14, the most obvious small and micro enterprises, the press conference of the joint defense and joint control mechanism of the State Council introduced the relevant situation of increasing financial and tax support for epidemic prevention and control and increasing financial support for enterprises affected by the epidemic, especially small and micro enterprises After the outbreak of the epidemic, the financial departments at all levels issued a series of fiscal and tax security policies to ensure funds At the same time, the Ministry of finance has also established a daily report system for epidemic prevention and control funds in the national financial system, which tracks the guarantee of local funds in real time As of February 13, finance at all levels has spent 80.55 billion yuan on epidemic prevention and control, of which 17.29 billion yuan has been allocated by the central government In addition, Fu Jinling, director of the office of the leading group of the Ministry of Finance and director of the Department of social security, said at the meeting that small and micro enterprises were most affected by the epidemic, especially labor-intensive industries such as planting and breeding, wholesale and retail, accommodation and catering, logistics and transportation, cultural tourism, manufacturing and export The Ministry of finance, together with relevant departments, has issued a series of financial policies to help important medical material enterprises, enterprises that provide information, communication services and service systems in response to the epidemic, enterprises that undertake the corresponding tasks of material transportation and sales, and other key guarantee enterprises to enjoy the central financial policy discount "These policies focus on enterprises directly related to epidemic prevention and control, and are helping key enterprises to resume production and operation as soon as possible In the next step, we will do a good job in policy reserve with foresight and pertinence, help small and medium-sized micro enterprises reduce the burden, and return to work as soon as possible Novel coronavirus pneumonia was once again in Wuhan to fight against the epidemic In February 13th, the Military Commission approved by the chairman of the Central Military Commission Xi Jinping sent 2600 additional medical and nursing personnel to support the Wuhan against the new crown pneumonia epidemic situation According to the operation mode of Wuhan's Fire God Mountain hospital, the hospital was responsible for the medical treatment of the patients in the Optics Valley Hospital of Taikang Tongji Hospital and Hubei maternal and child health care hospital According to reports, the medical strength of the selected group came from the army, Navy, air force, rocket force, strategic support force, joint service support force and armed police force According to the capacity and construction progress of the hospital, the military medical staff will be put into support in batches The first 1400 people will arrive in Wuhan on February 13, and the relevant medical treatment work will be carried out in the first time China's novel coronavirus pneumonia patients were supported by the WHO confirmed the diagnosis of clinical diagnosis In February 13th, WHO said that it fully supported the adoption of clinical diagnosis results of new crown pneumonia cases in Hubei Province, which believed that this would help patients get faster clinical care The number of cases increased Novel coronavirus pneumonia in Hubei province (14840 cases including 13332 cases of clinical diagnosis) was reported in Hubei on February 12th, when the -24 health and Health Committee announced that the number of new cases of acute pneumonia increased suddenly This figure has aroused people's attention This is because, novel coronavirus infection pneumonia diagnosis and treatment plan (trial version fifth), the case of suspected cases in Hubei with pneumonia imaging characteristics, included in the clinical diagnosis In part, it's because of a change in reporting "Although the number of confirmed cases reported in China has increased significantly in terms of figures, this does not represent a significant change in the trajectory of the epidemic." Meanwhile, no novel coronavirus pneumonia mortality rate and severe proportion have been found The novel coronavirus pneumonia test in Hubei area is still negative or not detected by nucleic acid, but the imaging features of patients with new crown pneumonia criteria are included in clinical diagnosis cases This is conducive to the precise implementation of policies for such patients who have not yet been diagnosed, which is not only conducive to the treatment of patients, but also conducive to the overall prevention and control of the epidemic The novel coronavirus of market dynamics International Committee on Taxonomy of viruses was named SARS-CoV-2 The disease was named COVID-19 in February 11th The international group of virus classification coronavirus research group (Coronavirusstudygroup) issued a statement, officially naming the new coronavirus (2019-nCoV) as severe acute respiratory syndrome coronavirus 2 (severeacuterespiratorysyndromecoronavirus2, SARS-CoV-2) This indicates that the novel coronavirus is a near cousin of SARS coronavirus (SARS-CoV) from a taxonomic perspective The World Health Organization (who) also announced on the same day that the official name of the disease caused by the virus is covid-19 Covid-19 means a disease caused by a coronavirus infection that broke out in 2019 Dr tedros adhanom ghebreyesus, director general of the World Health Organization, said at a regular press conference that the name could help prevent the use of other inaccurate or stigmatized names The novel coronavirus is related to the hog bat coronavirus In February 12th, WHO's latest outbreak reported that more and more evidences showed that 2019-nCoV (2019 Coronavirus) was associated with other known coronavirus transmitted in bats, and more specifically, it was associated with Phinolophusbat, a bat species Rhinolophus is widespread in southern China and throughout Asia, the Middle East, Africa and Europe According to the report, the latest research shows that more than 500 kinds of coronaviruses have been detected in bats in China According to the serological study of the rural population living near the natural habitat of cave bats, the positive rate of bat coronavirus is 2.9%, which indicates that human contact with bat coronavirus may be very common However, the report also pointed out that the initial route of transmission of the outbreak is still unclear At present, the most likely situation is that some intermediate host animals have transmitted the virus to humans Novel coronavirus animal infection sources are being sought by Chinese and foreign experts The source will help prevent similar epidemic in the future, and help understand the initial infection path of the epidemic Hubei has seized more than 460 cases of fake and dirty respirators and the amount involved is 660 Yu Wanyuan On February 12, according to chinanews.com, Hubei public security organs investigated 9 criminal cases of fake and shoddy protective materials, arrested 12 suspects, destroyed 8 fakes manufacturing and selling dens, seized more than 4.6 million fake masks, more than 300000 sets of shoddy protective clothing, and involved more than 6.6 million yuan At present, Hubei Provincial Public Security Bureau announced 5 typical cases of manufacturing and selling fake and shoddy protective materials during the epidemic on the 12th The first novel coronavirus pneumonia cases were the four generation of infection cases in Chongqing, and the three generation of infection cases increased In February 13th, the Chongqing health authority's official website announced that as of February 12th, at 24 o'clock, in the current situation of Chongqing's new crown pneumonia, three cases of the new cases accounted for a significant increase The source also found that in February 10th, 2 cases of four generation of infection cases occurred in Chongqing Novel coronavirus pneumonia was reported in Chongqing at 24 hours in February 12th 518 cases were diagnosed as severe pneumonia, 29 cases were severe cases, 24 cases were critical cases, 3 cases were death cases and 102 cases were discharged A total of 18925 close contacts have been traced, 11755 have been removed from medical observation, and 7170 are undergoing medical observation Experts believe that with the continuous increase of the investigation of suspected cases in all parts of the city, the scope of close contacts has also expanded, indirectly protecting the susceptible population, and the proportion of suspected to confirmed cases and close contacts to confirmed cases has a downward trend, which will play a positive role in the next week's epidemic prevention and control However, among the new cases, the proportion of third-generation infection cases was significantly higher It was also found that on February 10, two cases of fourth generation infection cases first appeared in the city, the infection chain was extended, and the difficulty of prevention and control was further increased Successful expression of recombinant "s-trimer" vaccine of new coronavirus in Trifolium repens On February 10, Trifolium biopharmaceuticals announced that the company successfully expressed the recombinant protein vaccine of "s-trimer" new coronal pneumonia virus (2019-ncov) in mammalian cells, and with the strong assistance of Chengdu hi tech Zone government and Chengdu public health clinical medical center, the newly obtained "s-trimer" antigen was used to detect the virus in the serum of many patients with virus infection after rehabilitation Specific antibody According to the clover bio press release, this is the first time in the world to disclose that a candidate for a new coronavirus vaccine can be recognized by antibodies of patients infected with the virus This result shows that the "s-trimer" recombinant vaccine retains the natural structure of the new coronavirus S-protein antigen, so the "s-trimer" vaccine is expected to induce a protective immune response in human body Borui pharmaceutical: the bulk production of radcivir APIs was announced on the evening of February 11, and Borui pharmaceutical announced that the company has successfully copied and developed the synthesis process technology and preparation technology of radcivir APIs, and has mass produced radcivir APIs, and the batch production of radcivir preparations is in progress It is worth noting that, although Borui pharmaceutical has completed the imitation and preparation production of radcivir API, it still needs to go through the clinical trial, drug approval and other links There will be significant uncertainty in the process if ridceway is ultimately converted into a product for the market, with the authorization of Gilead, the original research company The novel coronavirus pneumonia antibody is expected to reduce the mortality of critically ill patients in February 13th China biological group released good news on the progress of treatment of new crown pneumonia, said it has completed the collection of plasma from some rehabilitation patients, and has prepared the new crown virus special plasma products and the special protein After strict blood biological safety test, virus inactivation, antiviral activity test, etc., we have successfully prepared the special plasma for clinical treatment, which has been used in Wuhan Institute of biological products of China biology, Wuhan blood products Co., Ltd of State Pharmaceutical Group, the first people's Hospital of Jiangxia District, Wuhan Blood Center, Wuhan Institute of virus of Chinese Academy of Sciences, China food and drug inspection With the close cooperation of the Research Institute, we put into clinical treatment of severe patients Since February 8th, the novel coronavirus pneumonia diagnosis and treatment plan (trial version fifth) has been launched as the guideline The first time in Jiangxia District First People's hospital has launched 3 new critical plasma treatment for critically ill patients At present, more than 10 critically ill patients have been treated with the follow-up hospital Clinically, 12 to 24 hours after treatment, the main inflammatory indicators were tested in the laboratory
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.